Monday 7th December 2020
|Text too small?|
Further to the announcement by Ryman Healthcare Limited (Ryman) of an offer of up to $100 million (with the ability to accept oversubscriptions of up to an additional $50 million at Ryman’s discretion) of 6 year, secured fixed rate bonds maturing on 18 December 2026, Ryman today announced indicative pricing for the offer.
The indicative issue margin range is 2.00% to 2.20% per annum over the underlying swap rate, subject to a minimum interest rate of 2.50% per annum.
The actual issue margin may be above or below the indicative issue margin range. The issue margin and interest rate will be set following a bookbuild process on 10 December 2020 and will be announced by Ryman via NZX shortly thereafter.
The offer opens today and will close on 10 December 2020 following the bookbuild process, with the bonds expected to be issued on 18 December 2020.
Full details of the bond offer are contained in the Product Disclosure Statement (PDS). The PDS is available through www.rymanhealthcare.co.nz/investors/bonds or by contacting the Joint Lead Managers or your usual financial adviser, and must be obtained by investors before they decide to acquire any bonds.
Ryman has applied for the bonds to be quoted on the NZX Debt Market.
There is no public pool for the bonds, with all of the bonds being reserved for the Joint Lead Managers, NZX participants and other approved financial intermediaries invited to participate in the bookbuild.
See the links below for more details:
No comments yet
Greenfern Industries Limited (Greenfern) Normanby Power Station Gets Green Light
Just Life Group Limited (NZX: JLG) to Acquire Business of About Health and Raise Capital
Tourism Holdings Limited (NZX: THL) Market Update
Delegat Group Limited (NZX: DGL) 2021 Harvest Announcement
Kiwi Property Group Limited (NZX: KPG) Gives Green Light to New Sylvia Park Office Building
Just Life Group Limited (NZX: JLG) Invests in Domestic Rainwater Tank Business
NZME Limited (NZX: NZM) NZ Markets Disciplinary Tribunal Censures
Rua Bioscience Limited (NZX: RUA) Announces CCO with Global Pharma Experience
Cannasouth Limited (NZX: CBD) Supply Activity Added to Cannasouth Commercial Licence
Skellerup Holdings Limited (NZX: SKL) Upgrades FY21 Earnings Guidance